Kiniksa Pharmaceuticals Ltd.(KNSA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KNSA Kiniksa Pharmaceuticals Ltd.

休市中 05-03 16:00:00 EDT

20.08

+0.70

+3.61%

盘后20.08

+0.000.00%

17:05 EDT

最高20.40	最低19.62	成交量40.24万
今开20.13	昨收19.38	日振幅4.02%
总市值14.24亿	流通市值6.03亿	总股本7,094万
成交额805.03万	换手率1.34%	流通股本3,003万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KNSA","market":"US","secType":"STK","nameCN":"Kiniksa Pharmaceuticals Ltd.","latestPrice":20.08,"timestamp":1714766400000,"preClose":19.38,"halted":0,"volume":402366,"hourTrading":{"tag":"盘后","latestPrice":20.08,"preClose":20.08,"latestTime":"17:05 EDT","volume":7769,"amount":155994.68,"timestamp":1714770300519},"delay":0,"floatShares":30033255,"shares":70940145,"eps":0.12308,"marketStatus":"休市中","marketStatusCode":7,"change":0.7,"latestTime":"05-03 16:00:00 EDT","open":20.13,"high":20.4,"low":19.62,"amount":8050284.632688,"amplitude":0.040248,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.12308,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":1527134400000,"adjPreClose":19.38,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":20.14,"preClose":19.38,"latestTime":"09:29 EDT","volume":5236,"amount":104792.84323200001,"timestamp":1714742999999},"postHourTrading":{"tag":"盘后","latestPrice":20.08,"preClose":20.08,"latestTime":"17:05 EDT","volume":7769,"amount":155994.68,"timestamp":1714770300519},"volumeRatio":0.8405881439302421},"requestUrl":"/m/hq/s/KNSA","defaultTab":"news","newsList":[{"id":"2432518834","title":"Kiniksa Pharmaceuticals(KNSA.US)获富国银行首次覆盖，给予增持评级, 目标价34.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432518834","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432518834?lang=zh_cn&edition=full","pubTime":"2024-05-04 00:05","pubTimestamp":1714752314,"startTime":"0","endTime":"0","summary":"Kiniksa Pharmaceuticals(KNSA.US)获富国银行首次覆盖，给予增持评级, 目标价34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040005198b70c8c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040005198b70c8c1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432261638","title":"Kiniksa Pharmaceuticals, Ltd.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432261638","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432261638?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:42","pubTimestamp":1714588936,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时42分，Kiniksa Pharmaceuticals, Ltd.股票出现波动，股价大幅上涨5.24%。Kiniksa Pharmaceuticals, Ltd.股票所在的生物技术行业中，整体涨幅为1.75%。Kiniksa Pharmaceuticals, Ltd.公司简介：Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司，专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。该信息摘要如下：小摩：维持Kiniksa Pharmaceuticals评级，由增持调整至增持评级, 目标价由26.00美元调整至30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502024216861ea927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502024216861ea927&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432501614","title":"小摩：维持Kiniksa Pharmaceuticals(KNSA.US)评级，由增持调整至增持评级, 目标价由26.00美元调整至30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432501614","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432501614?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:55","pubTimestamp":1714575342,"startTime":"0","endTime":"0","summary":"小摩：维持Kiniksa Pharmaceuticals(KNSA.US)评级，由增持调整至增持评级, 目标价由26.00美元调整至30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012255468b6a27f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012255468b6a27f0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429112842","title":"Kiniksa Pharmaceuticals, Ltd.盘中异动 快速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429112842","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429112842?lang=zh_cn&edition=full","pubTime":"2024-04-24 00:03","pubTimestamp":1713888181,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日00时03分，Kiniksa Pharmaceuticals, Ltd.股票出现波动，股价快速上涨5.06%。Kiniksa Pharmaceuticals, Ltd.股票所在的生物技术行业中，整体涨幅为1.38%。Kiniksa Pharmaceuticals, Ltd.公司简介：Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司，专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240003017a54f36b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240003017a54f36b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400865436","title":"Kiniksa Pharmaceuticals Ltd盘中异动 股价大涨5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2400865436","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400865436?lang=zh_cn&edition=full","pubTime":"2024-01-02 22:35","pubTimestamp":1704206134,"startTime":"0","endTime":"0","summary":"北京时间2024年01月02日22时35分，Kiniksa Pharmaceuticals Ltd股票出现异动，股价快速上涨5.99%。Kiniksa Pharmaceuticals Ltd股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Longboard Pharmaceuticals Inc、Zura Bio Limited C/Wts 20/03/2028 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Soligenix Inc、Kintara Therapeutics Inc、Longboard Pharmaceuticals Inc较为活跃，换手率分别为209.48%、163.54%、37.74%，振幅较大的相关个股有Longboard Pharmaceuticals Inc、Soligenix Inc、Absci Corp，振幅分别为64.34%、26.41%、16.80%。Kiniksa Pharmaceuticals Ltd公司简介：Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司，专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240102223534861c7f0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240102223534861c7f0f&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kiniksa.com","stockEarnings":[{"period":"1week","weight":0.123},{"period":"1month","weight":0.1009},{"period":"3month","weight":0.0925},{"period":"6month","weight":0.2395},{"period":"1year","weight":0.4808},{"period":"ytd","weight":0.1448}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kiniksa Pharmaceuticals, Ltd.于2015年7月21日在百慕大成立.该公司是一家生物制药公司，专注于发现、获取、开发和商业化治疗药物，为患有严重未满足医疗需求的使人衰弱的疾病的患者提供治疗药物。该公司的免疫调节组合ARCALYST、KPL-404和mavrilimumab基于强大的生物学原理或经过验证的机制，针对一系列未得到充分治疗的心血管和自身免疫疾病，并提供差异化的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.001355},{"month":2,"riseRate":0.666667,"avgChangeRate":0.05427},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.08579},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.018132},{"month":5,"riseRate":0.666667,"avgChangeRate":0.013096},{"month":6,"riseRate":0.833333,"avgChangeRate":0.070947},{"month":7,"riseRate":0.5,"avgChangeRate":-0.015801},{"month":8,"riseRate":0.333333,"avgChangeRate":0.024457},{"month":9,"riseRate":0.5,"avgChangeRate":-0.000526},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.120523},{"month":11,"riseRate":1,"avgChangeRate":0.236104},{"month":12,"riseRate":0.666667,"avgChangeRate":0.060395}],"exchange":"NASDAQ","name":"Kiniksa Pharmaceuticals Ltd.","nameEN":"Kiniksa Pharmaceuticals Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kiniksa Pharmaceuticals Ltd.(KNSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kiniksa Pharmaceuticals Ltd.(KNSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kiniksa Pharmaceuticals Ltd.,KNSA,Kiniksa Pharmaceuticals Ltd.股票,Kiniksa Pharmaceuticals Ltd.股票老虎,Kiniksa Pharmaceuticals Ltd.股票老虎国际,Kiniksa Pharmaceuticals Ltd.行情,Kiniksa Pharmaceuticals Ltd.股票行情,Kiniksa Pharmaceuticals Ltd.股价,Kiniksa Pharmaceuticals Ltd.股市,Kiniksa Pharmaceuticals Ltd.股票价格,Kiniksa Pharmaceuticals Ltd.股票交易,Kiniksa Pharmaceuticals Ltd.股票购买,Kiniksa Pharmaceuticals Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kiniksa Pharmaceuticals Ltd.(KNSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kiniksa Pharmaceuticals Ltd.(KNSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}